From 13 till 17 September 2024: HIGHLIGHTS FROM ESMO
Your direct line with Barcelona
The European Society of Medical Oncology (ESMO) 2024 brings together leading experts in the different fields of cancer from around the world. And this year they gather together in Barcelona, Spain. The MediMix team is also onsite, and will – together with your Belgian colleagues – keep you posted about the hottest topics as they happen. And, we dive into posters and hot topics with the experts as they are being presented.
Stay tuned, and get ready for an exciting and informative journey!
Presidential highlights
Anal cancer, while relatively rare, has seen a rising incidence in recent years. Approximately 40% of patients with anal cancer will either experience relapse following primary treatment or develop de
Daily highlights in GI
In this video Dr Ana-Maria Bucalau discusses and comments on the data of some interesting studies that were presented at ESMO 2024 during the mini-oral session on upper digestive gastrointestinal
Prof Dr Hans Prenen, medical oncologist at the University Hospital Antwerp selected three abstracts from the mini oral session on lower GI tumours.
The OPERA trial, published in The Lancet
In this video, Prof Dr Marc Van den Eynde discusses and comments on the data of some interesting studies that were presented at ESMO 2024 during the proffered paper session
In this video, Prof Dr Karen Geboes discusses and comments on the data of some interesting studies that were presented at ESMO 2024 during the proffered paper session on upper
In this video, Dr Francesco Sclafani, digestive oncologist at the Institut Jules Bordet,
summarises the key results of four clinical trials that were presented during the second proffered paper session
In this video, Prof Dr Jeroen Dekervel, digestive oncologist at the University Hospitals Leuven discusses two clinical trials that were presented during a first proffered paper session on upper digestive
In-depth stories about GI
In this video Prof Dr Eric Van Cutsem and Prof Dr Scott Kopetz talk us through the updated results of the safety lead-in of the BREAKWATER trial presented at ESMO
Survivors of rectal cancer often face bowel problems known as Low Anterior Resection Syndrome (LARS). This complication can have a profound impact on the quality of life of patients. During
In this video Prof Dr Eric Van Cutsem (University Hospitals Leuven) and Prof Dr Scott Kopetz (MD Anderson Cancer Center, Houston, TX, USA) discuss the results of a phase II
Prof Dr Eric Van Cutsem (University hospitals Leuven) meets up with Dr Sara Lonardi, digestive oncologist at the Instituto Oncologico Veneto IOV-IRCSS in Padova, Italy.
In this video, Prof Dr Eric Van Cutsem (University Hospitals Leuven) discusses these clinically relevant findings with Prof Dr Gerald Prager, digestive oncologist at the Medical University of Vienna and
GI poster selection
In her research project, Dr Amelie Franken (VIB-KU Leuven Center for Cancer Biology, Leuven, Belgium) used data from this study to evaluate whether the spatial organization of tumours was associated
Made possible with the financial support of our partners.
All videos are developed independently and are non-promotional.
